What is the price target for UROY stock?
8 analysts have analysed UROY and the average price target is 4.07 USD. This implies a price increase of 17.61% is expected in the next year compared to the current price of 3.46.
NASDAQ:UROY • CA91702V1013
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for URANIUM ROYALTY CORP (UROY).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2025-04-22 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-12-19 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-10-07 | B. Riley Securities | Initiate | Buy |
| 2024-09-17 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-06-17 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-03-11 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-12-08 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-08-22 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-05-31 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-03-20 | HC Wainwright & Co. | Maintains | Buy |
| 2022-10-11 | HC Wainwright & Co. | Maintains | Buy |
| 2022-08-23 | HC Wainwright & Co. | Maintains | Buy |
| 2022-05-25 | HC Wainwright & Co. | Maintains | Buy |
| 2021-09-29 | HC Wainwright & Co. | Maintains | Buy |
| 2021-05-21 | Canaccord Genuity | Upgrade | Hold |
| 2021-03-31 | Canaccord Genuity | Upgrade | Hold |
| 2021-02-16 | HC Wainwright | Upgrade | Buy |
| 2021-02-16 | Canaccord Genuity | Upgrade |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 13.85M | 42.706M 208.35% | 15.595M -63.48% | 58.58M 275.63% | 1.01M -98.28% | 4.04M 300.00% | |
| EBITDA YoY % growth | -3.76M 31.51% | 7.1M 288.83% | -4.686M -166.00% | 2.424M 151.73% | -8.08M -433.33% | -5.05M 37.50% | |
| EBIT YoY % growth | -3.78M 31.15% | 7.077M 287.22% | -4.806M -167.91% | -4.99M -3.84% | 34.441M 790.14% | 27.62M -19.80% | |
| Operating Margin | -27.29% | 16.57% | -30.82% | -8.52% | 3,410.00% | 683.66% | |
| EPS YoY % growth | N/A -40.00% | N/A 200.00% | N/A -104.76% | 0.02 600.60% | -0.02 -219.98% | -0.04 -100.00% |
All data in CAD
| Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.01 | 0.00 100.00% | 0.00 -100.00% | 0.00 -100.00% | 0.00 100.00% |
| Revenue Q2Q % growth | N/A | N/A | N/A | N/A | N/A |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | N/A | N/A | N/A | N/A | N/A |
All data in CAD
8 analysts have analysed UROY and the average price target is 4.07 USD. This implies a price increase of 17.61% is expected in the next year compared to the current price of 3.46.
URANIUM ROYALTY CORP (UROY) will report earnings on 2026-07-14.
The number of analysts covering URANIUM ROYALTY CORP (UROY) is 8.